The influence of menopausal hormone therapy on tumour characteristics and survival in endometrial cancer patients
- 30 November 2009
- journal article
- Published by Elsevier in European Journal of Cancer
- Vol. 45 (17) , 3064-3073
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Menopausal hormone therapy in relation to breast cancer characteristics and prognosis: a cohort studyBreast Cancer Research, 2008
- Recent trends of cancer in Europe: A combined approach of incidence, survival and mortality for 17 cancer sites since the 1990sEuropean Journal of Cancer, 2008
- Socioeconomic Inequalities in Health in 22 European CountriesNew England Journal of Medicine, 2008
- Patient survival for all cancers combined as indicator of cancer control in EuropeEuropean Journal of Public Health, 2008
- Survival for eight major cancers and all cancers combined for European adults diagnosed in 1995–99: results of the EUROCARE-4 studyThe Lancet Oncology, 2007
- Ovarian cancer and hormone replacement therapy in the Million Women StudyThe Lancet, 2007
- Use of hormone replacement therapy before and after ovarian cancer diagnosis and ovarian cancer survivalInternational Journal of Cancer, 2006
- Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled TrialJAMA, 2002
- Estrogen replacement in surgical stage I and II endometrial cancer survivorsAmerican Journal of Obstetrics and Gynecology, 1996
- Endometrial Carcinoma: Histopathology, Survival, and Exogenous EstrogensGynecologic and Obstetric Investigation, 1981